# ğŸ“ˆ Cipla Stock Analysis Report

## ğŸ“Œ Project Overview
This project provides a comprehensive technical analysis of **Cipla Limited**, a leading global pharmaceutical company based in India. By analyzing historical stock data from **1996 to 2024**, this report identifies long-term price trends, the impact of external global events (such as COVID-19), and the stock's stability as an investment option.

## ğŸ¯ Objectives
* **Analyze Historical Trends:** Trace the stock's performance over nearly three decades.
* **Identify Market Phases:** Segment the timeline into Bullish, Bearish, and Stabilization phases.
* **Assess External Impacts:** Evaluate how events like the COVID-19 pandemic influenced stock value.
* **Determine Investment Viability:** Conclude on the stock's reliability and long-term growth potential.

## ğŸ“‚ Dataset
The analysis uses daily stock market data covering the period **Jan 1, 1996 â€“ Nov 13, 2024**.
* **Columns:** `Date`, `Open`, `High`, `Low`, `Close`, `Adj Close`, `Volume`
* **Source:** Historical stock data (NSE/BSE).

## ğŸ” Key Insights & Observations

### 1. Market Phases Identified
* **Bullish Period (2000 â€“ 2016):** A long phase of strong upward price movement driven by positive fundamentals.
* **Bearish Phase (2016 â€“ 2020):** A period of significant price decline and correction attributed to changing investor sentiment and market factors.
* **COVID-19 Surge (2020):** A rapid price increase reflecting the critical role of the pharmaceutical sector during the pandemic.
* **Steady Growth (2021 â€“ 2024):** The stock has stabilized and returned to a predictable upward trajectory, signaling long-term recovery.

### 2. Performance Metrics
* **Long-Term Stability:** Cipla has demonstrated consistent growth, with notable peaks during high-demand healthcare periods.
* **Investor Confidence:** High trading volumes during critical periods indicate strong market sentiment.
* **Decadal Returns:** Over the last decade (2014â€“2024), the stock has provided positive average annual returns, validating its reliability.

## ğŸ› ï¸ Tech Stack
* **Language:** Python
* **Analysis:** Pandas, NumPy
* **Visualization:** Matplotlib / Seaborn (Line plots for closing prices, volume analysis)

## ğŸš€ How to Run
1.  **Clone the repository:**
    ```bash
    git clone [https://github.com/yourusername/cipla-stock-analysis.git](https://github.com/yourusername/cipla-stock-analysis.git)
    ```
2.  **Install dependencies:**
    ```bash
    pip install pandas matplotlib seaborn
    ```
3.  **Run the notebook:**
    ```bash
    jupyter notebook Cipla_Analysis.ipynb
    ```

## ğŸ“¢ Conclusion
The analysis confirms that **Cipla remains an attractive option for long-term growth**. Its ability to recover from the 2016â€“2020 bearish phase and capitalize on the post-pandemic market conditions demonstrates strong fundamentals and resilience in the global pharmaceutical sector.

## ğŸ“„ License
This project is open-source and available under the [MIT License](LICENSE).
